Krystal Biotech Inc is a pioneering biotechnology firm based in Pittsburgh, Pennsylvania, focused on developing genetic medicines for rare diseases. The company has made significant strides with its flagship product, VYJUVEK, designed to treat dystrophic epidermolysis bullosa, a severe skin condition. Additionally, Krystal Biotech is advancing a diverse pipeline of treatments targeting conditions such as congenital ichthyosis, netherton syndrome, cystic fibrosis, and aesthetic skin issues, among others, through various stages of clinical trials.
Wall Street flipped the script Friday with a wave of surprise upgrades and downgrades hitting names like Wayfair, Roku, and Fox Corporation, while cooler inflation data reshuffled bets across stocks, bonds, oil,…
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from cap-weighted peers and creates…
